These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

93 related items for PubMed ID: 531273

  • 1. [Effect of saralasin infusion on glomerular filtration rate and sodium excretion in hypertensive patients (author's transl)].
    de Franca Borges H, da Silva Saragoça MA, Kater CE, Ribeiro AB, Ajzen H, Ramos OL.
    Rev Bras Pesqui Med Biol; 1979 Sep; 12(4-5):293-302. PubMed ID: 531273
    [Abstract] [Full Text] [Related]

  • 2. Glomerular and tubular antinatriuretic actions of low-dose angiotensin II infusion in man.
    Eiskjaer H, Sørensen SS, Danielsen H, Pedersen EB.
    J Hypertens; 1992 Sep; 10(9):1033-40. PubMed ID: 1328362
    [Abstract] [Full Text] [Related]

  • 3. Effects of saralasin infusion on bilateral renal function in two-kidney, one-clip Goldblatt hypertensive rats.
    Huang WC, Ploth DW, Navar LG.
    Clin Sci (Lond); 1982 Jun; 62(6):573-9. PubMed ID: 7083749
    [Abstract] [Full Text] [Related]

  • 4. The use of saralasin in the recognition of angiotensinogenic hypertension.
    Streeten DH, Dalakos TG, Anderson GH.
    Prog Biochem Pharmacol; 1976 Jun; 12():214-26. PubMed ID: 1019165
    [Abstract] [Full Text] [Related]

  • 5. Atrial natriuretic peptide counteracts angiotensin-II-induced impairment of renal function.
    Schafferhans K, Heidbreder E, Hummel S, Heidland A.
    Z Kardiol; 1988 Jun; 77 Suppl 2():78-84. PubMed ID: 2970179
    [Abstract] [Full Text] [Related]

  • 6. Effects of angiotensin II on renal sodium handling and diluting capacity in man pretreated with high-salt diet and enalapril.
    Vos PF, Koomans HA, Boer P, Dorhout Mees EJ.
    Nephrol Dial Transplant; 1992 Jun; 7(10):991-6. PubMed ID: 1331894
    [Abstract] [Full Text] [Related]

  • 7. The effect of an angiotensin antagonist (saralasin) on arterial pressure and plasma aldosterone in hemodialysis-resistant hypertensive patients.
    Mimran A, Shaldon S, Barjon P, Mion C.
    Clin Nephrol; 1978 Feb; 9(2):63-7. PubMed ID: 639368
    [Abstract] [Full Text] [Related]

  • 8. Pressure-dependent distal tubular action of atrial natriuretic peptide in healthy humans.
    Eiskjaer H, Nielsen CB, Pedersen EB.
    J Hypertens; 1996 Jan; 14(1):99-106. PubMed ID: 12013501
    [Abstract] [Full Text] [Related]

  • 9. Angiotensin II natriuresis and anti-natriuresis: role of renal artery pressure in anaesthetized dogs.
    Olsen ME, Hall JE, Montaini JP, Guyton AC.
    J Hypertens Suppl; 1984 Dec; 2(3):S347-50. PubMed ID: 6599679
    [Abstract] [Full Text] [Related]

  • 10. [Renovascular hypertension: prediction of surgical treatment by angiotensin II blockade and saralasin (author's transl)].
    Mimran A, Deschodt G, Barjon P, Mary H, Thevenet A.
    Nouv Presse Med; 1978 Dec 02; 7(43):3889-93. PubMed ID: 733540
    [Abstract] [Full Text] [Related]

  • 11. Subpressor doses of angiotensin II do not increase albumin excretion in humans.
    Erley CM, Grau C, Furian TC, Wolf S, Braun N, Risler T.
    Clin Nephrol; 1996 Nov 02; 46(5):312-8. PubMed ID: 8953120
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Angiotensin II: enhanced renal responsiveness in young genetically hypertensive rats.
    Vyas SJ, Jackson EK.
    J Pharmacol Exp Ther; 1995 May 02; 273(2):768-77. PubMed ID: 7752079
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. The effects of the angiotensin II antagonist saralasin on blood pressure and plasma aldosterone in man in relation to the prevailing plasma angiotensin II concentration.
    Brown JJ, Brown WC, Fraser R, Lever AF, Morton JJ, Robertson JI, Rosei EA, Trust PM.
    Prog Biochem Pharmacol; 1976 May 02; 12():230-41. PubMed ID: 1019166
    [Abstract] [Full Text] [Related]

  • 16. Renal tubular sensitivity to atrial natriuretic factor in essential hypertension.
    Janssen WM, de Zeeuw D, van der Hem GK, de Jong PE.
    J Hypertens; 1994 Apr 02; 12(4):439-47. PubMed ID: 8064168
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Control of renal function by intrarenal angiotensin II.
    Levens NR, Freedlender AE, Peach MJ, Carey RM.
    Endocrinology; 1983 Jan 02; 112(1):43-9. PubMed ID: 6847833
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. The effects of an angiotensin blocker (saralasin) on kidney function in dehydrated sheep.
    Yesberg NE, Henderson M, Wilson K, Law S, Cross RB.
    Q J Exp Physiol; 1982 Jan 02; 67(1):97-103. PubMed ID: 7079453
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.